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Available online xxxxThis study aimed to investigate possible relationships between sedentary behavior and body mass index (BMI),
cardiorespiratory fitness (CRF), and health-related quality of life (HRQoL) in schizophrenia patients. Variables
contributing to the variability in sedentary behavior were identified. Eighty-two schizophrenia outpatients
(mean age ± SD: 41.0 ± 8.7 years, 87% men, mean illness duration ± SD: 17.1 ± 8.9 years) wore a multisensor
armband for 7 consecutive full days to objectivelymeasure sedentary behavior. BMI, walking capacity (6-minute
walking test) as a proxy for CRF estimation andHRQoL (Short Form36-ItemHealth Survey questionnaire version
2) were also assessed. Correlation (Pearson or Spearman coefficients) and multiple regression analysis were
used. Sedentary behavior was significantly associated with BMI, CRF, and the physical component summary
score of HRQoL (r values, −0.34–0.41; all P b 0.001) and remained significant after adjustments for age, illness
duration, symptom severity, adherence to Mediterranean diet, smoking, and antipsychotic medication (all P b
0.05). BMI, CRF and vitality were identified as determinants of sedentary behavior. Consistent relationships be-
tween sedentary behavior and BMI, CRF, and the physical component summary score of HRQoL were found in
schizophrenia patients. All the identified determinants of sedentary behavior are modifiable and may be impor-
tant areas for future interventions in this population.





Quality of life1. Introduction
Sedentary behavior (SB), defined as any waking activity character-
ized by energy expenditure ≤1.5metabolic equivalentswhile in a sitting
or reclining posture (Sedentary Behaviour Research Network, 2012),
has been described as a major public health problem (Blair, 2009).
High levels of SB are associated with increased risk of morbi-mortality,
independent of physical activity (Biswas et al., 2015). Recentmeta-anal-
yses reported that severe mental illness patients including schizophre-
nia were more sedentary than controls (Stubbs et al., 2016b;
Vancampfort et al., 2017a). Despite the increased mortality (Walker et
al., 2015), mainly due to cardiovascular disease (Correll et al., 2017;
Vancampfort et al., 2016, 2015c), research on health effects of SB in
schizophrenia patients is scarce.
A key factor in improving the understanding of the health effects of
SB and the effectiveness of interventions aimed to reduce SB time in
schizophrenia patients is to use adequate methods for quantifying SB.




, J., et al., Relationship betwe
je..., Schizophr. Res. (2017), het al., 2017a) suggest, self-report measures fail to capture the SB levels
in schizophrenia, highlighting the need to prioritize the use of objective
measures to obtain more accurate results. However, few studies have
utilized objective measures of SB in schizophrenia patients, and all
existing studies included modest sample sizes (n b 50) (e.g., (Gomes
et al., 2014; Janney et al., 2013; Snethen et al., 2014)), except for three
recent inpatient studies (Chen et al., 2016; Stubbs et al., 2017b,
2017a). Therefore, studies that objectively measure SB in schizophrenia
patients, including outpatient studies with relatively large sample sizes,
are needed.
It is well-known that schizophrenia patients have worse health-re-
lated quality of life (HRQoL) (Foldemo et al., 2014), higher prevalence
of overweight/obesity (assessed as body mass index; BMI)
(Subramaniam et al., 2014), and impaired cardiorespiratory fitness
(CRF) (Vancampfort et al., 2015b, 2017b) compared with the general
population, largely as a result of unhealthy lifestyle choices such as
lack of physical activity, poor diet, and smoking (Dipasquale et al.,
2013; Stubbs et al., 2016a). However, little is known regarding the ex-
tent to which SB in schizophrenia patients is associated with BMI and
HRQoL, and the relationship between SB and CRF remains unexplored.
The primary aim of this study was to investigate possible relation-
ships between objectively measured SB and BMI, CRF, and HRQoL in
schizophrenia patients. A secondary aim was to identify variables that
could explain the variability in SB.en objectively measured sedentary behavior and health outcomes in
ttps://doi.org/10.1016/j.schres.2017.11.022
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2.1. Participants and setting
This was a cross-sectional study. From July 2014 to May 2016, adult
outpatients with an established ICD-10 diagnosis of schizophrenia and
stabilized on antipsychotic medication during the last month were re-
cruited from 13 mental healthcare settings in southern Spain. Patients
with clinical instability, co-morbid substance abuse, or evidence of un-
controlled cardiovascular, neuromuscular and endocrine disorders
were excluded. Two visits per patient were scheduled. During the first
appointment, anthropometric, sociodemographic, and medical record
data were registered. In addition, patients were asked to wear a
multisensor for 9 days, starting the same day they received themonitor.
On day 9, during the second appointment, patients returned the moni-
tor and completed standardized questionnaires about HRQoL, symptom
severity, diet, and smoking. Finally, CRF was examined using a field-
based test. The procedure was approved by the Universidad Pablo de
Olavide Ethics Committee. All patients gave their informedwritten con-
sent prior to enrolling and after receiving information about the study
aims and protocol. There was no compensation for participation.
2.2. SB
SB that involved anywaking activity characterized by energy expen-
diture ≤1.5 metabolic equivalents, was objectively assessed using the
SenseWearPro3Armband (BodyMedia, Inc., Pittsburgh, PA, USA), previ-
ously used in non-clinical (Scheers et al., 2013) and clinical populations
(Bond et al., 2011). Energy expenditure was accurately estimated
(Johannsen et al., 2010) using data recorded from multiple sensors (a
two-axis accelerometer and sensors measuring heat-flux, galvanic skin
response and near body-temperature) and manufacturer-specific algo-
rithms (SenseWear Professional software, version 8.1). Patients were
required to wear the SenseWear on the triceps muscle of their left
arm for 9 consecutive days, except when showering or swimming,
and were asked to follow their usual lifestyle. The first and last days
were excluded from the analysis to minimize reactivity (Corder et al.,
2008). A total of 7 days of recording with a minimum of 1368 min per
day (95% of a 24-hour period) was necessary for inclusion in the analy-
sis. Although SB data are expressed both inminutes and as a percentage
of waking time, only the relative SB time was used for analysis to ac-
count for individual differences in waking time.
2.3. Anthropometric data
Weight and height were measured with light clothing and without
shoes to the nearest 0.1 kg and 0.1 cm using a scale (TANITA BC-420;
Tanita, Tokyo, Japan) and a stadiometer, respectively, and BMI was
calculated.
2.4. CRF
The 6-minute walking test, a feasible, reliable and valid method for
assessing walking capacity in schizophrenia patients (Gomes et al.,
2016), was used as a measure-of-proxy CRF estimation, as proposed
by others (Vancampfort et al., 2015b). The test was performed accord-
ing to Rikli and Jones (1999) on an indoor coursewith aflat,firm surface
and with minimal external stimuli. Patients were instructed to walk as
far as possible during a 6-minute period around a 45.7-meter rectangu-
lar course delimited by cones, without running or jogging. Resting was
allowed if necessary, butwalkingwas to be resumed as soon as possible.
Standardized encouragements were used as recommended (Rikli and
Jones, 1999). The same trained instructor explained the protocol, gave
a demonstration prior to start, supervised the test and recorded the
total distance walked to the nearest 0.1 m for each patient.Please cite this article as: Bueno-Antequera, J., et al., Relationship betwe
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We used the Short Form 36-Item Health Survey version 2 (SF-36)
(Ware and Sherbourne, 1992), which demonstrated good psychometric
properties in schizophrenia patients (Su et al., 2014). The SF-36 exam-
ines eight domains of physical (physical functioning, physical role,
body pain, and general health) and mental HRQoL (vitality, social func-
tioning, emotional role, and mental health). The four physical-domains
are summarized into a physical component score (PCS), and the four
mental-domains constitute a mental component score (MCS). Scores
range from 0 to 100, with higher scores indicating better HRQoL. A
five-point difference (domain-scores) and two- to three-point differ-
ence (summary-scores) are considered clinically relevant (Ware et al.,
1994).
2.6. Symptom severity
The severity of psychiatric symptoms during the previous week was
assessed using the Brief Symptoms Inventory-18 (Derogatis, 2001),
which is recommended as a more economical variant of the Symptom
Checklist 90-R and as a clinically meaningful instrument (Prinz et al.,
2013). Scores range from 0 to 72, with higher scores indicating higher
severity.
2.7. Adherence to Mediterranean diet
We used the 14-Item Mediterranean Diet Tool (Martinez-Gonzalez
et al., 2012) to assess the adherence to Mediterranean diet. Scores
range from 0 to 14; scores ≥ 8 indicate high adherence, established as
protective in terms of morbi-mortality (Sofi et al., 2014).
2.8. Smoking, illness-related factors and antipsychotic medication data
Smoking was self-reported. Age, diagnosis, illness duration, and an-
tipsychotic medication were retrieved from patients' medical records.
Antipsychotic medication was converted into a daily equivalent dosage
of chlorpromazine (Gardner et al., 2010).
2.9. Statistical analysis
Student's t-test was used to calculate differences in SB according to
gender, adherence to Mediterranean diet, and smoking. Patients were
divided into low and high levels of SB using the median split, and Chi-
square, Student's t, andMann–WhitneyU testswere applied to establish
differences according to the nature and distribution of variables. Adjust-
ments for multiple comparisonsweremade using the Bonferronimeth-
od by dividing the significance level of 0.05 by the number of
comparisons; in this case, 0.05/20 = 0.0025. To quantify relationships
between SB and BMI, CRF or HRQoL, Pearson or Spearman correlation
coefficients were used, depending on whether the data followed a nor-
mal distribution. Correlations were corrected for age, illness duration,
symptom severity, adherence toMediterranean diet, smoking, and anti-
psychotic medication. Correlation values were interpreted as follows:
b0.25, weak or null; 0.25–0.50, fair; 0.50–0.75, moderate to good; and
N0.75, good to excellent. Multiple stepwise regression model analysis
was applied to identify significant determinants (independent vari-
ables) for SB (dependent variable). To prevent overfitting, significant
correlates from the univariate tests were included in the model. Only
patients with a complete dataset for the significant correlated variables
were included in themultiple regression analysis. Variance inflation fac-
tor values N 3 were used to indicate a multicollinearity problem in the
model (Kleinbaumet al., 2013). Graphic and statistical analyses of resid-
ualswere used to verify normality, linearity and homoscedasticity of the
regression analysis. The datawere analysed in 2016using SPSS Statistics
for Windows, Version 22.0 (Armonk, NY: IBM Corp).en objectively measured sedentary behavior and health outcomes in
ttps://doi.org/10.1016/j.schres.2017.11.022
Table 2
Characteristic comparisons of sedentary behavior levels in schizophrenia patients.
Variables % or mean (SD) Low sedentary High sedentary P⁎
na Values na Values
Age (years) 41 40.7 ± 8.6 41 41.3 ± 8.9 0.7361
Severity of psychiatric symptoms
(0–72)b
38 12.0 ± 10.3 40 19.1 ± 11.9 0.0045








Body mass index (kg/m2) 41 28.8 ± 3.8 41 32.6 ± 6.0 0.0018⁎





Short Form 36-Item Health Survey
(0–100)
Physical function 40 78.3 ± 24.2 39 69.1 ± 21.9 0.0200
Physical role 40 73.9 ± 23.0 39 70.8 ± 25.3 0.5847
Pain 40 74.7 ± 22.4 39 64.7 ± 24.4 0.0777
General health 40 64.0 ± 23.3 39 53.8 ± 21.6 0.0612
Vitality 40 59.7 ± 18.2 39 46.8 ± 23.3 0.0065
Social function 40 67.2 ± 23.5 39 59.9 ± 31.7 0.2825
Emotional role 40 70.8 ± 26.4 39 69.7 ± 29.8 0.9678
Mental health 40 65.0 ± 17.8 39 60.1 ± 23.4 0.2989
Physical component summary 40 50.4 ± 8.9 39 46.3 ± 9.1 0.0478
Mental component summary 40 42.9 ± 10.8 39 40.5 ± 13.8 0.3891
Gender (women) 41 4 (9.8) 41 9 (22.0) 0.1310
Adherence to Mediterranean diet
c
35 14 (40.0) 36 14 (38.9) 0.9242
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Eighty-two of the 95 (86%) participants had valid SenseWear data.
Reasons for invalid SenseWear data included refusal to wear the device
(n=1), unregistered data attributed to technical problems (n=4), and
unmet wear-time criteria (n= 8). Patients' characteristics are summa-
rized in Table 1. In total, 13%, 38% and 49% of the patients were normal-
weight, overweight and obese, respectively.Meanpercentage ofwaking
time spent in SB was 58.7 (range 27.1–92.5) which corresponds to
8.8 h/day (range 3.9–13.2). No differences in SB were found between
men andwomen (57.5± 13.7 and 65.3±12.7% of waking time, respec-
tively; P=0.061), between non-smokers and current smokers (60.9 ±
13.3 and 56.9±14.1%, respectively; P=0.190) and between thosewith
low and high adherence toMediterranean diet (59.6 ± 12.6 and 59.6±
14.6%, respectively; P = 0.995).
Characteristic comparisons of SB levels are shown in Table 2. The
high-SB group had a significantly higher BMI than the low-SB group
(P = 0.0018). Differences in HRQoL were clinically significant for PCS,
MCS, and almost all SF-36 domains.
The simple correlationmodel between SB and sample characteristics
is presented in Table 3. Significant correlations with SB were found for
symptom severity, BMI, CRF, and HRQoL, specifically in physical func-
tion, pain, and vitality domains and in PCS (all P b 0.05). The associations
between BMI, CRF, and HRQoL remained significant after adjusting forTable 1
Patients' characteristics (n = 82).
Variables Values
Age (years) 41.0 ± 8.7
Severity of psychiatric symptoms (0–72)a,b 15.6 ± 11.6
Illness duration (years)a 17.1 ± 8.9
Chlorpromazine equivalent dose (mg/day)a 756.8 ± 568.5
Sedentary time (% of waking time) 58.7 ± 13.8
Body mass index (kg/m2) 30.7 ± 5.3
6-Minute walking test (m)a 589.6 ± 90.6
Short Form 36-Item Health Surveya (0−100)
Physical function 73.7 ± 23.4
Physical role 72.4 ± 24.1
Pain 69.7 ± 23.8
General health 59.0 ± 22.9
Vitality 53.3 ± 21.7
Social function 63.6 ± 27.9
Emotional role 70.3 ± 28.0
Mental health 62.6 ± 20.7
Physical component summary 48.4 ± 9.1
Mental component summary 41.7 ± 12.3
Gender (women) 13 (15.9)
Adherence to Mediterranean diet (high)a,c 28 (39.4)






Unfinished studies 16 (20.3)
Primary school 29 (36.7)
Secondary school 28 (35.4)





Values are in mean ± SD or n (%). Sedentary data are for an average day.
a Missing data. Reasons: Incomplete patient medical record data for illness dura-
tion and chlorpromazine equivalent dose (n = 4 and 9, respectively); incomplete
questionnaire data for severity of psychiatric symptoms (n= 4), Short Form 36-Item
Health Survey (n = 3), and adherence to the Mediterranean diet (n = 11); incom-
plete 6-minute walking test (n = 1).
b Severity of psychiatric symptoms was assessed using the Spanish version of the Brief
Symptoms Inventory-18, with higher scores indicating high severity of psychiatric
symptoms.
c Adherence toMediterranean diet was assessed using the 14-ItemMediterranean Diet
Tool, with scores ≥ 8 indicating high adherence to Mediterranean diet.
(high)
Smoking status (current smoker) 41 26 (63.4) 41 19 (46.3) 0.1201
The sample was divided into low levels of sedentary behavior (n = 41, b59% of waking
time, which corresponds to 7.3 h/day) and high levels of sedentary behavior (n = 41,
≥59% of waking time, which corresponds to 10.4 h/day) using themedian split of the per-
centage of waking time spent engaging in sedentary behavior.
a n varies due to missing data. Reasons: Incomplete patient medical record data for ill-
ness duration and chlorpromazine equivalent dose (n = 4 and 9, respectively); incom-
plete questionnaire data for severity of psychiatric symptoms (n = 4), Short Form 36-
Item Health Survey (n = 3), and adherence to the Mediterranean diet (n = 11); incom-
plete 6-minute walking test (n = 1).
b Severity of psychiatric symptoms was assessed using the Spanish version of the Brief
Symptoms Inventory-18, with higher scores indicating high severity of psychiatric
symptoms.
c Adherence toMediterranean diet was assessed using the 14-ItemMediterranean Diet
Tool, with scores ≥ 8 indicating high adherence to Mediterranean diet.
⁎ Significant when P b 0.0025.
Please cite this article as: Bueno-Antequera, J., et al., Relationship betwe
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diet, smoking, and antipsychotic medication; exceptions were pain
and vitality domains (P = 0.329 and 0.135, respectively; data not
shown). Additional analysis found that the association between SB
and CRF remained significant and fair even when BMI was included
with the rest of the confounders (P = 0.018; data not shown).
Due to some missing data, a subsample of 74 patients (63 men and
11 women)with no changes in the correlation coefficients of the signif-
icant correlates (all P b 0.05; data not shown) was included in the mul-
tiple regression analysis (Table 4).Within the fully adjustedmodel, BMI,
CRF, and vitalitywere identified as determinants of SB, explaining 37.4%
of the SB variability. Therewas nomulticollinearity among the variables
within the final model.
4. Discussion
The main findings are the identification of BMI, CRF, and vitality as
determinants of SB, with higher BMI, lower CRF andworse PCS score as-
sociatedwith amore sedentary lifestyle. The statistical power of the cor-
relations remained after adjustments for age, illness duration, symptom
severity, adherence to Mediterranean diet, smoking, and antipsychotic
medication, highlighting the importance of considering SB as a health
risk behavior in schizophrenia patients.
The finding showing the association between SB and BMI in schizo-
phrenia patients is consistent with previous studies that used self-re-
ported SB (Vancampfort et al., 2014, 2012) but inconsistent with
studies that used objective SB measurements (Janney et al., 2013;en objectively measured sedentary behavior and health outcomes in
ttps://doi.org/10.1016/j.schres.2017.11.022
Table 3
Relationship between sedentary behavior and sample characteristics.
Variables na Correlation P
Age (years) 82 −0.01 0.914
Severity of psychiatric symptoms (0–72)b 78 0.26 0.020⁎
Illness duration (years) 78 −0.04 0.736
Chlorpromazine equivalent dose (mg/day) 73 −0.11 0.377
Body mass index (kg/m2) 82 0.41 b0.001⁎
6-Minute walking test (m) 81 −0.34 b0.001⁎
Short Form 36-Item Health Survey (0–100)
Physical function 79 −0.35 0,002⁎
Physical role 79 −0.35 0,291
Pain 79 −0.24 0,036⁎
General health 79 −0.19 0,087
Vitality 79 −0.37 0,001⁎
Social function 79 −0.15 0,176
Emotional role 79 0.01 0,934
Mental health 79 −0.13 0,240
Physical component summary 79 −0.35 b0.001⁎
Mental component summary 79 −0.08 0,480
Gender (men/women) 82 0.21 0.061
Adherence to Mediterranean diet (low/high)c 71 0.00 0.995
Smoking status (non-smoker/current smoker) 82 0.15 0.190
Correlation values are either Pearson or Spearman correlations.
a n varies due to missing data. Reasons: Incomplete patient medical record data for ill-
ness duration and chlorpromazine equivalent dose (n = 4 and 9, respectively); incom-
plete questionnaire data for severity of psychiatric symptoms (n = 4), Short Form 36-
Item Health Survey (n = 3), and adherence to the Mediterranean diet (n = 11); incom-
plete 6-minute walking test (n = 1).
b Severity of psychiatric symptoms was assessed using the Spanish version of the Brief
Symptoms Inventory-18, with higher scores indicating high severity of psychiatric
symptoms.
c Adherence toMediterranean diet was assessed using the 14-ItemMediterranean Diet
Tool, with scores ≥ 8 indicating high adherence to Mediterranean diet.
⁎ Significant when P b 0.05.
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aforementioned studies could be explained by the limited statistical
power of the sample size (n b 50), the ceiling effect observed for BMI
(Janney et al., 2013; Snethen et al., 2014) or the use of different devices
and requirements to evaluate objective SB. Other research in schizo-
phrenia (Stubbs et al., 2017b) also found no association between SB ob-
jectively measured and waist circumference, suggested as a better
predictor of cardiovascular risk than BMI (Janssen et al., 2004). None-
theless, current studies reported that no obesity index is consistently
superior to others (Lam et al., 2015) and that the combined obesity in-
dices had a better predictive capacity than either alone (Tao et al.,
2016). Future studies investigating the association between combined
obesity indices and SB measured objectively through energy expendi-
ture and body position for multiple and consecutive 24-hour periods
are necessary to gain better insights into this issue.
The finding demonstrating the relationship between SB and BMI in-
dependent of various confounders, including diet, may be explained by
the use of total SB time instead of time spent engaging in certain SBs
such as television viewing, that are associatedwith weight gainmediat-
ed by unhealthy dietary patterns (de Rezende et al., 2014). FutureTable 4
Final model of the backward stepwise regression analysis with the mean percentage of
waking time spent engaging in sedentary behavior as the dependent variable (n = 74).
Variablesa B SE β t VIF P
(Constant) 61.12 14.45 4.23
Body mass index 0.93 0.26 0.35 3.50 1.15 0.001⁎
6-Minute walking test −0.04 0.02 −0.24 −2.28 1.27 0.026⁎
Vitality −0.16 0.07 −0.25 −2.53 1.13 0.014⁎
B: unstandardized coefficient; β: standardized coefficient; SE: standard error; VIF: vari-
ance inflation.
a Only significant correlates in the univariate tests were included in themodel (severity
of psychiatric symptoms, bodymass index, 6-minute walking test, physical function, pain,
vitality and physical component summary).
⁎ Significant when P b 0.05.
Please cite this article as: Bueno-Antequera, J., et al., Relationship betwe
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patterns using appropriate tools (Bueno-Antequera et al., 2017a) is re-
quired to improve the understanding of the impact of specific SBs on
BMI and on other health outcomes of schizophrenia patients.
A significant relationship between SB and CRF can be expected be-
cause SB has a deleterious impact on circulatory, respiratory andmuscu-
lar systems (Allen et al., 1999) involved in CRF. Similar results have been
recently found in psychosis patients (Bueno-Antequera et al., 2017b),
and the association persisted even when BMI was included with the
rest of the confounders. These findings are of clinical interest because
a low CRF is associated with an enhanced risk of cardiovascular disease,
all-cause mortality, and mortality rates attributable to various cancers
(Ross et al., 2016). Therefore, regardless of BMI, reducing SBmay protect
against two critical health issues in schizophrenia patients - impaired
CRF (Vancampfort et al., 2015b) and elevated premature mortality
(Olfson et al., 2015) - suggesting a shift in clinical focus from fatness to-
wards fitness in this population, as previously proposed (Vancampfort
et al., 2017b). Future research should investigatewhether these findings
are applicable considering other health-related fitness components,
such as muscular strength, which is also impaired in schizophrenia pa-
tients (Vancampfort et al., 2013) and is related to mortality (Volaklis
et al., 2015).
The significant association between SB and the HRQoL PCS score
could be attributable to a higher BMI and lower CRF in more sedentary
patients (see Table 3), which were significantly related to the HRQoL
PCS (r = −0.27 and 0.43, respectively; both P b 0.05; data not
shown), consistent with previous research in schizophrenia patients
(Vancampfort et al., 2015a). In addition to the PCS, lower clinically rele-
vant scores for MCS were found in the high-SB group, suggesting possi-
ble associations between mental aspects of HRQoL and SB in line with a
longitudinal study of older adults (Balboa-Castillo et al., 2011). These re-
sults are inconsistent with the one study that investigated the relation-
ship between SB and HRQoL in schizophrenia patients (Gomes et al.,
2014). The small sample size employed (n = 8) in the aforementioned
study (Gomes et al., 2014) and the use of different tools to measure
HRQoL and SB may explain the discrepancy.
Finally, the relationship between SB and symptom severity did not
remain significant in the multiple regression model, suggesting that its
importance in SB in schizophrenia patients is weak and can be ex-
plained by its interaction with other variables. All the identified deter-
minants of SB are modifiable and may be important areas for future
interventions in this population. It should be noted that our model
only explained approximately a third of variability in SB suggesting
that other outcomes not included in this study such as the socioeco-
nomic (Stamatakis et al., 2014), geographical (Vancampfort et al.,
2017a), and environmental status (Vancampfort et al., 2014) could ex-
plain part of the remaining variability.
As for clinical implications, this study could help to raise health pro-
fessionals' awareness of the importance of reducing excessive SB in
schizophrenia patients. However, randomized controlled trials aimed
to reduce SB in schizophrenia patients are needed to determine wheth-
er reduced health outcomes can be improved (Williams et al., 2016). Re-
searchers should consider all reported determinants of SB in this work
when designing trials.
The findings need to be interpreted cautiously. The major limitation
of this study is the cross-sectional design. Longitudinal and intervention
studies are needed to identify any causal relationships. The convenience
sample of outpatients, predominantly men, may also affect generaliza-
tion. Future research should determine whether the results are also ap-
plicable in inpatient settings and for women with schizophrenia. The
absence of a control group is an additional limitation. The objective SB
measurement employed also presents limitations. The SenseWear de-
vice is unable to differentiate body position (i.e., sitting, lying, and
standing). However, it may solve the limitations of accelerometers and
inclinometers through heat production measurements and placement
on the upper arm. Further studies using multiple sensors anden objectively measured sedentary behavior and health outcomes in
ttps://doi.org/10.1016/j.schres.2017.11.022
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sure SB. CRF was estimated through a submaximal exercise test that
evaluates walking capacity. Future studies should confirm our findings
using maximal or submaximal tests with direct measurement of peak
oxygen uptake, the gold standard for CRF assessment (Vanhees et al.,
2005). Finally, data on symptom severity and diet were collected with
self-report questionnaires. This may involve recall bias (Raphael,
1987) that could be even more pronounced in schizophrenia patients,
who are prone to memory and cognitive difficulties (Hill et al., 2013).
Despite these limitations, this study has strengths. Major strengths
of this multicenter study are the relatively large sample size and the
strict requirements used to measure SB. All patients wore the
SenseWear for 7 consecutive days with at least 1368 min/day of regis-
tered time, and reactivity was minimized. Another strength was the ad-
justment for confounders that could influence the relationships
between SB and BMI, CRF, and HRQoL. These include age, illness dura-
tion, symptom severity, adherence to Mediterranean diet, smoking,
and antipsychotic medication. Finally, using the relative SB time to
avoid the potential confounding influence of waking time could be con-
sidered another strength.
In conclusion, consistent relationships between higher SB and
higher BMI, lower CRF and worse HRQoL PCS scores were found in
schizophrenia patients. In addition, lower clinically relevant scores for
HRQoL PCS and MCS were found in the high-SB group. Finally, BMI,
CRF, and vitality were identified as determinants of SB. Therefore, re-
ducing SB may lead to improvements in health outcomes that are com-
monly impaired in schizophrenia patients.
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